Skip to content
AnalystLens
Back to GILDCash Flow

GILEAD SCIENCES, INC. Free Cash Flow 2013-2026 | GILD

Annual FY2013–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$9.46B

−8.2%YoY vs FY2024Source: 10-KFY2025

From $2.97B in FY2013 to $9.46B in FY2025: 3.2× in 12 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$2.4B+46.8%Not reportedNot reportedNot reported
FY25$1.7B−21.8%$720M−39.7%$4.0B−5.0%$3.1B+10.4%
FY24$2.1B+29.3%$1.2B−45.7%$4.2B+155.2%$2.8B+44.7%
FY23$1.6B+2.6%$2.2B+32.5%$1.6B−39.7%$2.0B−18.1%
FY22$1.6B−34.8%$1.7B−24.5%$2.7B−13.1%$2.4B−21.7%
Share19%21%32%28%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionStable
CAGR

+4.7%

FY2020
$7.52B
FY2025
$9.46B

5 years selected · on the chart

01—History

Free Cash Flow History

Year-over-year comparison from 10-K annual reports

  9. $9.46B
YoY changeLargest recent move+151.6%in FY18Latest −8.2%

1 older move runs past ±150% (largest +151.6%); point at, tap or drag across the bars to read one.

02—Ledger

Free Cash Flow, period by period

PeriodValueChangeSource
FY2025$9.46B−8.2%10-K
FY2024$10.30B+38.9%10-K
FY2023$7.42B−11.1%10-K
FY2022$8.34B−22.8%10-K
FY2021$10.80B+43.7%10-K
FY2020$7.52B−9.6%10-K
FY2019$8.32B+11.3%10-K
FY2018$7.48B+151.6%10-K
FY2013$2.97B—10-K

03—Questions

What is GILEAD SCIENCES, INC.'s current free cash flow?

GILEAD SCIENCES, INC. (GILD) annual free cash flow for 2025 was $9.46B, a 8.24% decline from 2024. GILEAD SCIENCES, INC. free cash flow for the quarter ending March 31, 2026 was $2.43B.

What was GILEAD SCIENCES, INC.'s free cash flow in 2024?

GILEAD SCIENCES, INC. annual free cash flow for 2024 was $10.30B, a 38.86% increase from 2023.

What was GILEAD SCIENCES, INC.'s free cash flow in 2023?

GILEAD SCIENCES, INC. annual free cash flow for 2023 was $7.42B, a 11.06% decline from 2022.

What is GILEAD SCIENCES, INC.'s 5-year free cash flow CAGR?

GILEAD SCIENCES, INC. free cash flow grew at a compound annual growth rate (CAGR) of 4.69% from FY2020 to FY2025, going from $7.52B to $9.46B over 5 years.

Company
GILEAD SCIENCES, INC.
Ticker
GILD
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
View company profile →